FI900633A0 - Menetelmä nifedipiinipitoisen farmaseuttisen seoksen valmistamiseksi - Google Patents

Menetelmä nifedipiinipitoisen farmaseuttisen seoksen valmistamiseksi

Info

Publication number
FI900633A0
FI900633A0 FI900633A FI900633A FI900633A0 FI 900633 A0 FI900633 A0 FI 900633A0 FI 900633 A FI900633 A FI 900633A FI 900633 A FI900633 A FI 900633A FI 900633 A0 FI900633 A0 FI 900633A0
Authority
FI
Finland
Prior art keywords
nifedipine
pharmaceutical composition
polyvinylpyrrolidone
amount
preparation
Prior art date
Application number
FI900633A
Other languages
English (en)
Swedish (sv)
Other versions
FI95347C (fi
FI95347B (fi
Inventor
Allan Rhodes
Original Assignee
Ethical Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethical Pharma Ltd filed Critical Ethical Pharma Ltd
Publication of FI900633A0 publication Critical patent/FI900633A0/fi
Application granted granted Critical
Publication of FI95347B publication Critical patent/FI95347B/fi
Publication of FI95347C publication Critical patent/FI95347C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
FI900633A 1989-02-14 1990-02-08 Menetelmä nifedipiinipitoisen farmaseuttisen seoksen valmistamiseksi FI95347C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8903328 1989-02-14
GB898903328A GB8903328D0 (en) 1989-02-14 1989-02-14 Nifedipine-containing pharmaceutical compositions and process for the preparation thereof

Publications (3)

Publication Number Publication Date
FI900633A0 true FI900633A0 (fi) 1990-02-08
FI95347B FI95347B (fi) 1995-10-13
FI95347C FI95347C (fi) 1996-01-25

Family

ID=10651674

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900633A FI95347C (fi) 1989-02-14 1990-02-08 Menetelmä nifedipiinipitoisen farmaseuttisen seoksen valmistamiseksi

Country Status (17)

Country Link
US (1) US5145683A (fi)
EP (1) EP0385582B1 (fi)
JP (1) JPH07112974B2 (fi)
AT (1) ATE79032T1 (fi)
AU (1) AU626130B2 (fi)
CA (1) CA2008972C (fi)
DE (1) DE69000240T2 (fi)
DK (1) DK0385582T3 (fi)
ES (1) ES2052168T3 (fi)
FI (1) FI95347C (fi)
GB (1) GB8903328D0 (fi)
GR (1) GR3005477T3 (fi)
IE (1) IE64682B1 (fi)
NO (1) NO175925C (fi)
NZ (1) NZ232287A (fi)
PH (1) PH26850A (fi)
ZA (1) ZA90904B (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US5662933A (en) * 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
ATE212838T1 (de) * 1994-12-29 2002-02-15 Shire Deutschland Gmbh & Co Kg Pharmazeutische zubereitungen, enthaltend nifedipin und verfahren zu ihrer herstellung
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
CN1049114C (zh) * 1995-12-07 2000-02-09 上海华联制药公司 一种制备缓释药物制剂的方法
EP0859603B1 (en) 1996-07-08 2008-12-17 Penwest Pharmaceuticals Co. Sustained release matrix for high-dose insoluble drugs
EP0852141A1 (en) 1996-08-16 1998-07-08 J.B. Chemicals & Pharmaceuticals Ltd. Nifedipine containing pharmaceutical extended release composition and a process for the preparation thereof
IT1284604B1 (it) * 1996-09-27 1998-05-21 Roberto Valducci Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6168806B1 (en) 1999-03-05 2001-01-02 Fang-Yu Lee Orally administrable nifedipine pellet and process for the preparation thereof
US20040115134A1 (en) * 1999-06-22 2004-06-17 Elan Pharma International Ltd. Novel nifedipine compositions
JP4627825B2 (ja) * 1999-09-27 2011-02-09 三生医薬株式会社 被包粒状物質及びその製造方法
CA2352211C (en) * 1999-09-30 2009-03-24 Edward Mendell Co., Inc. Sustained release matrix systems for highly soluble drugs
DE60028754T2 (de) * 1999-11-12 2007-05-31 Abbott Laboratories, Abbott Park Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
KR20030034171A (ko) * 2001-07-06 2003-05-01 엔도 파마슈티걸즈, 인크. 옥시모르폰 제어 방출 제형
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
EP2112925A4 (en) * 2006-11-15 2013-01-09 Abbott Lab SOLID PHARMACEUTICAL DOSAGE FORMULATIONS
GB2462022B (en) * 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
RU2629843C1 (ru) * 2016-05-24 2017-09-04 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Способ получения мази нифедипина (варианты)
CN109172534B (zh) * 2018-10-23 2020-08-07 迪沙药业集团有限公司 一种硝苯地平缓释片剂组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
US4285665A (en) * 1978-05-08 1981-08-25 Johnson, Matthey & Co., Limited Engines
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
DE3424553A1 (de) * 1984-07-04 1986-01-09 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa

Also Published As

Publication number Publication date
JPH07112974B2 (ja) 1995-12-06
US5145683A (en) 1992-09-08
CA2008972C (en) 1996-09-03
DE69000240T2 (de) 1993-02-11
DK0385582T3 (da) 1992-09-14
CA2008972A1 (en) 1990-08-14
ZA90904B (en) 1991-06-26
IE900286L (en) 1990-08-14
NO175925B (no) 1994-09-26
NZ232287A (en) 1992-01-29
GB8903328D0 (en) 1989-04-05
FI95347C (fi) 1996-01-25
AU626130B2 (en) 1992-07-23
DE69000240D1 (de) 1992-09-10
NO900370L (no) 1990-08-15
PH26850A (en) 1992-11-05
ATE79032T1 (de) 1992-08-15
NO900370D0 (no) 1990-01-26
EP0385582B1 (en) 1992-08-05
EP0385582A1 (en) 1990-09-05
JPH02235815A (ja) 1990-09-18
ES2052168T3 (es) 1994-07-01
GR3005477T3 (fi) 1993-05-24
FI95347B (fi) 1995-10-13
AU4893790A (en) 1990-08-23
IE64682B1 (en) 1995-08-23
NO175925C (no) 1995-01-04

Similar Documents

Publication Publication Date Title
FI900633A0 (fi) Menetelmä nifedipiinipitoisen farmaseuttisen seoksen valmistamiseksi
AU561633B2 (en) Tablet with a slow or zero order release rate
NZ221962A (en) Oral pharmaceutical compositions comprising a mixture of ibuprofen and aluminium hydroxide and process for their preparation
FI945476A0 (fi) Hitaasti vapautuvat koostumukset ja menetelmä farmaseuttisten koostumusten valmistamiseksi
CA2127111A1 (en) A Method for Preparing Enteric-Coated Oral Drugs Containing Acid-Unstable Compounds
FI940585A (fi) Pinnoittamattomat tabletit ja menetelmä niiden valmistamiseksi
EP0068450A3 (en) Pharmaceutical forms for oral administration
FI894899A0 (fi) Menetelmä dispergoituvan kiinteän lääkeainekoostumuksen valmistamiseksi
DK0519950T3 (da) Præparat
AU566228B2 (en) Compressed hydroxybutryic acid polymer retarded release vehicle
IT1229502B (it) Composizioni contenenti bismuto idonee per uso terapeutico.
FR2477015B1 (fi)
MX9704043A (es) Surtido de farmaco de liberacion sostenida empleando una goma de hidrocoloide en polvo obtenible a partir de plantas superiores.
ES8402819A1 (es) Procedimiento para la produccion de una 3,3-dialquil-o 3,3-dialquileno-indolina.
WO1997004750A3 (en) Process for preparing solid dosage forms of very low-dose drugs
EP0403882A3 (en) Indole derivatives and processes for preparation thereof
MY100752A (en) Pharmaceutical composition for combating malaria.
ATE181828T1 (de) Oral anzuwendendes arzneimittel bestehend aus ibuprofen
YU20050409A (sh) Kompozicije oksikodona sa kontrolisanim oslobađanjem

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: ETHICAL PHARMACEUTICALS LTD